Jennifer Smith is the editor of Oncology Practice, part of MDedge Hematology/Oncology. She was previously the editor of Hematology Times, an editor at Principal Investigators Association, and a reporter at The Oneida Daily Dispatch. She has a BS in journalism.
News
Treatments linked to death in COVID patients with thoracic cancers
- Author:
- Jennifer Smith
Prior treatment with steroids, anticoagulants, chemotherapy alone, or chemo plus immunotherapy were all associated with an increased risk of death...
News
Nivolumab approved to treat esophageal squamous cell carcinoma
- Author:
- Jennifer Smith
Nivolumab is approved for use in previously treated, unresectable, advanced, recurrent, or metastatic esophageal...
News
Frontline nivo-ipi plus chemo approved for metastatic NSCLC
- Author:
- Jennifer Smith
The combination of nivolumab, ipilimumab, and platinum-doublet chemotherapy is approved as frontline treatment...
News
FDA approves brigatinib and companion diagnostic for NSCLC
- Author:
- Jennifer Smith
The FDA approved brigatinib to treat adults with ALK-positive metastatic non–small cell lung cancer and approved...
News

FDA expands approval of atezolizumab in NSCLC
- Author:
- Jennifer Smith
Atezolizumab is approved as first-line monotherapy for adults with metastatic non–s...
News

FDA approves olaparib/bevacizumab maintenance
- Author:
- Jennifer Smith
The FDA has approved a new indication for olaparib and a companion diagnostic for adults with advanced...
News

NSCLC: FDA approves capmatinib and companion assay
- Author:
- Jennifer Smith
Capmatinib is the first FDA-approved treatment for NSCLC with MET exon 14 skipping mutations.
News
Antitumor treatment may increase risk of severe events in COVID-19 patients
- Author:
- Jennifer Smith
Receiving antitumor treatment within 14 days of COVID-19 diagnosis was linked to a higher risk of ICU admission...
News
Metastatic cancer linked to worse outcomes of COVID-19
- Author:
- Jennifer Smith
Patients with hematologic malignancies or metastatic cancers had particularly high risks of developing severe or...
News

Mitomycin approved for low-grade upper tract urothelial cancer
- Author:
- Jennifer Smith
The FDA’s fast-track approval of mitomycin is based on results from the phase 3 OLYMPUS trial.
News

Barriers to clinical trial participation revealed by gynecologic cancer patients
- Author:
- Jennifer Smith
A survey suggests a lack of discussion about clinical trials between doctors and patients with gynecologic cancers.
News
Doublet may be beneficial in wild-type, advanced NSCLC
- Author:
- Jennifer Smith
About 77% of patients achieved a partial response or had stable disease on combination apatinib and vinorelbine.
News

Drug reduces oral mucositis without affecting tumor control
- Author:
- Jennifer Smith
Locoregional control, distant metastasis, and survival rates were similar in patients who received the drug, GC4419, and those who did not.
Article

Researchers honored by ACS, IASLC
- Author:
- Jennifer Smith
The ACS has awarded the 2020 Medal of Honor to three researchers, and the IASLC has named a lectureship after a...
News

10-year data show no benefit when adding cetuximab to radiation and cisplatin
- Author:
- Jennifer Smith
There was no survival benefit when cetuximab was added to radiotherapy and cisplatin in patients with head and neck carcinoma.